Compositions and methods for antibodies targeting complement protein C3b

Details for Australian Patent Application No. 2010252156 (hide)

Owner Novartis AG

Inventors Etemad-Gilbertson, Bijan; Guild, Braydon Charles; Kim, Yong-In; Klagge, Ingo; Kraus, Alexandra; Roguska, Michael; Splawski, Igor; Zhao, Kehao

Agent Davies Collison Cave

Pub. Number AU-A-2010252156

PCT Pub. Number WO2010/136311

Priority 61/175,860 06.05.09 US

Filing date 5 May 2010

Wipo publication date 2 December 2010

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/136311 Priority application(s): WO2010/136311

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010252158-Syngas production method

2010252151-Method for the simultaneous production of iron and a crude syngas containing CO and H2